期刊文献+

甲强龙预处理对大鼠脊髓损伤后claudin-5表达的影响

The effects of methylprednisolone pretreatment on the claudin-5 expression after spinal cord injury in rats
下载PDF
导出
摘要 目的探讨甲强龙(11β,17α,21-三羟基-6α-甲基孕甾-1,4-二烯-3,20二酮-21-琥珀酸钠)对大鼠脊髓损伤(spinal cord injury,SCI)后血-脊髓屏障(blood spinal cord barrier,BSCB)通透性及紧密连接蛋白claudin-5表达的影响。方法参照改良Allen’s法建立大鼠脊髓损伤模型。分为假手术组(n=50)、脊髓损伤组(n=50)、甲强龙预处理组(n=50)。建模后不同时间点(12h、1d、3d、5d、7d)各组随机取5只大鼠检测BSCB通透性,取胸段脊髓损伤区组织经RT-PCR、Western blot方法检测claudin-5表达。结果本实验制模成功率84.0%;脊髓损伤组各时间点EB含量较假手术组显著增高(F=27.732,P均<0.05)。甲强龙预处理组各时间点EB含量较脊髓损伤组显著降低(F=48.149,P均<0.05);脊髓损伤组各时间点claudin-5 m RNA表达较假手术组显著降低(F=12.248,P均<0.05)。甲强龙预处理组各时间点claudin-5 m RNA表达较脊髓损伤组显著升高(F=15.316,P均<0.05);脊髓损伤组各时间点claudin-5表达较假手术组显著降低(F=18.108,P均<0.05)。甲强龙预处理组各时间点claudin-5表达较脊髓损伤组显著升高(F=20.247,P均<0.05)。结论上调claudin-5表达可能是甲强龙改善大鼠脊髓损伤后血-脊髓屏障通透性的途径之一。 Objective To study the effects of methylprednisolone on the permeability of blood-spinal cord barrier (BSCB) and claudin-5 expression after spinal cord injury in rats. Methods The rat model of spinal cord injury was estab?lished using modified Allen method. SD rats were randomly divided into sham-operated group, spinal cord injury group and methylprednisolone pretreatment group. The permeability of BSCB and expression of claudin–5 were assessed at 12 h, 1, 3, 5, and 7 d after the onset of spinal cord injury (five animals per each time point). RT-PCR and Western blot were used to detect the expression of claudin-5. Results The success rate of the model was 84.0%. EB content was sig?nificantly higher in spinal cord injury group than in sham-operated group at each time point (F value 27.732,P〈0.05). EB content was lower in methylprednisolone pretreatment group than in spinal cord injury group (F value 48.149,P〈0.05). The mRNA expression of claudin-5 was lower in spinal cord injury group than sham-operated group at each time point (F value 12.248,P〈0.05). The mRNA expression of claudin–5 was higher in methylprednisolone pretreatment group than in spinal cord injury group at each time point (Fvalue 15.316,P〈0.05). The protein expression of claudin-5 was lower in spinal cord injury group than in sham operated group at each time point (Fvalue 18.108,P〈0.05). The pro?tein expression of Claudin-5 was higher in methylprednisolone pretreatment group than spinal cord injury group at each time point (F value 20.247,P〈0.05). Conclusions Methylprednisolone improves permeability of BSCB after spinal cord injury probably through enhancing claudin-5 expression in rats. 〈br〉 was lower in spinal cord injury group than in sham operated group at each time point (Fvalue 18.108,P〈0.05). The pro?tein expression of Claudin-5 was higher in methylprednisolone pretreatment group than spinal cord injury group at each time point (F value 20.247,P〈0.05). Conclusions Methylprednisolone improves permeability of BSCB after spinal cord injury probably through enhancing claudin-5 expression in rats.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2014年第12期741-745,共5页 Chinese Journal of Nervous and Mental Diseases
基金 重庆市教委自然科学基金资助(编号:KJ1400232) 重庆医科大学附属永川医院青年课题(编号:YJQN201419)
关键词 甲强龙 脊髓损伤 紧密连接 CLAUDIN-5 血-脊髓屏障 Methylprednisolone Spinal cord injury Tight junction Blood-spinal cord barrier Claudin-5
  • 相关文献

参考文献12

  • 1Viktor B, Daniela J, PharniD,et al. The hlood - spinal sord l)arri-ermiorpliology and clinical implications [J|.Ann eurol,2011,70(2):194-206.
  • 2Ellaine S.Sergey S.Carola F. Glucocorticoids anti endothelialcell harrier function|J]. Cell Tissue Res, 2014, 355(3):597 _ 605.
  • 3罗家明,秦新月,陈黎燕,尹红蕾.甲基强的松龙抑制实验性自身免疫性脑脊髓炎IL-23/IL-17轴机制研究[J].中国神经精神疾病杂志,2008,34(6):345-348. 被引量:10
  • 4崔敏,贺学农,周昌龙,夏小辉,张光伟.大鼠脊髓损伤后紧密连接蛋白claudin-5的表达[J].中国神经精神疾病杂志,2014,40(2):79-82. 被引量:3
  • 5Zeljka M,Miljana M,Djordje M, et al- Methylprednisolone inhib-its IFN-7 and IL-17 expression and production by cells infil-cephal.myelitis[J].J Neuroinflaniniation,2009,11(6):37.
  • 6Dong Upeng,Qiao Huimin, Zhang Xiangjian ,et al.Partheno-lide Is neurop rotective in rat experimental stroke model:Downregulating NF-kB, Phospho-p38MAPK, and Caspase-1and ameliorating BBB 丨)ei’meahility[jj. Mediators Innamm,2013,2013:370804.
  • 7Tobias V.Simon B,Mallhias 0,et al.Prolein kinase C(3 as a thera-peutic target slahilizing 1)1(><><1 - l)iain harrier disruption in ex-perimental autoimmune encephalomyelilis[J].Proc Natl Acad SciUSA,2013.110(36): 14735-丨 4740.
  • 8Grazyna B,Shadi N. Maternal glucocorticoid exposure altersAm J Physiol Heart Circ Physiol,2010,298(l):H179-H 188.
  • 9Edward A,Felinski,Amy E,et al.Glucocorticoids induce transacti-vation of tight junction genes occludin and claudin-5 in retinalendothelial cells viaa novel cis-element[J ].Exp Eye Res,2008,86(6):867-878.
  • 10Ken K,Hideki M,Masato Y. Inflammatory mediators weaken theanmiotic membrane barrier through disruption of tight junctions[J]. J Physiol 12010,588(24):4859-4869.

二级参考文献29

  • 1袁宝玉,秦新月,彭国光.PPARγ激动剂对实验性自身免疫性脑脊髓炎钙激活中性蛋白酶表达的影响[J].中国病理生理杂志,2007,23(5):955-958. 被引量:2
  • 2Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation [J]. J Clin Invest,2006,116(5):1218- 1222.
  • 3Koh CS, Paterson PY. Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor [ J ]. Cell-Immunol 1987,107 ( 1 ) : 52 - 63.
  • 4Gately MK, Renzetti LM, Magram J, et al. The interleukin-12/ interleukin-12-receptor system: role in normal and pathologic immune responses[ J]. Annu Rev Immunol, 1998,16:495 - 521.
  • 5Bartosik-Psujek H,Stelmasiak Z. Correlations between IL-4, IL- 12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients [J]. J Neural Transm, 2005,112 (6) :797 - 803.
  • 6Clerici M ,Saresella M ,Trabattoni D, et al. Single-cell a nalysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease [ J ]. J Neuroimmunol,2001,121 ( 1 - 2) :88 - 101.
  • 7Peltoniemi J, Broberg EK, Halenius A, et al. Immunomodulation by roquinimex decreases the expression of IL-23 (P19)mRNA in the brains of herpes simplec virus type 1 infected BALB/c mice [J]. Clin Exp Immunol,2004,137(2):305 -312.
  • 8angrish CI, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell populatkm that induces autoimmune inflammation [ J ]. J Exp Med ,2005,201 (2) :233 - 240.
  • 9Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain[J]. Nature,2003,421 (6924) :744 -748.
  • 10Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17- producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol, 2005, 6(11 ) :1123 -1132.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部